🇺🇸 FDA
Patent

US 6458799

Deazaguanine analog, preparation thereof and use thereof

expired A61KA61K31/519

Quick answer

US patent 6458799 (Deazaguanine analog, preparation thereof and use thereof) held by BioCryst Pharmaceuticals, Inc. expires Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue Oct 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/519